sulforaphane has been researched along with Allergic Encephalomyelitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copple, IM; Franklin, S; Galea, I; Howat, DW | 1 |
| Ahn, SW; Kim, J; Kim, MJ; Park, ST; Sung, JJ; Yoo, IH | 1 |
| Cui, W; Ge, XL; Guo, L; Li, B; Li, R; Liu, J; Liu, Q; Song, XJ; Wang, Y; Xie, XH; Zhang, J | 1 |
| Brück, J; Dengler, K; Geisel, J; Ghoreschi, K; Glocova, I; Röcken, M; Rothfuss, O; Schulze-Osthoff, K; Sinnberg, T; Walter, M | 1 |
4 other study(ies) available for sulforaphane and Allergic Encephalomyelitis
| Article | Year |
|---|---|
SFX-01 reduces residual disability after experimental autoimmune encephalomyelitis.
Topics: Animals; Anticarcinogenic Agents; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Isothiocyanates; Kaplan-Meier Estimate; Mice; Myelin Proteolipid Protein; Peptide Fragments; Sulfoxides; Time Factors; Treatment Outcome | 2019 |
The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Cervix Uteri; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Isothiocyanates; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Spinal Cord; Sulfoxides; Up-Regulation | 2019 |
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Topics: Animals; Antioxidants; Blotting, Western; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunohistochemistry; Inflammation; Isothiocyanates; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Electron, Transmission; Oxidative Stress; Real-Time Polymerase Chain Reaction; Spinal Cord; Sulfoxides; Th17 Cells | 2013 |
Sulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells.
Topics: Animals; Autoimmune Diseases; Cell Differentiation; Cluster Analysis; Cytokines; Dendritic Cells; DNA; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Profiling; Gene Expression Regulation; Heme Oxygenase-1; Interleukin-12; Interleukin-23; Isothiocyanates; Lymphocyte Activation; Mice; NF-kappa B; Phenotype; Protein Binding; Sulfoxides; T-Lymphocyte Subsets; Th1 Cells; Th17 Cells | 2014 |